Brazergoline
 | |
| Clinical data | |
|---|---|
| Other names | Luvion; 2-Bromo-6-methylergoline-8β-methanol hexahydro-1H-azepine-1-carboxylate |
| Drug class | Sympatholytic; Antihypertensive; Vasodilator |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H30BrN3O2 |
| Molar mass | 460.416 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Brazergoline (INN; synonym Luvion) is a drug described as a sympatholytic, antihypertensive, and vasodilator of the ergoline family which was never marketed.[1][2][3][4] It was reportedly investigated as a component of a condom with penile erection-promoting effects and as a potential treatment for female sexual dysfunction.[4] The drug was first described in the literature by 1976.[1]
See also
[edit]References
[edit]- 1 2 Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. ISBN 978-1-4757-2085-3. Retrieved 6 May 2026.
- ↑ Negwer M (1994). Organic-chemical Drugs and Their Synonyms: (an International Survey). Akademie Verlag. p. 2213. ISBN 978-3-05-501629-5. Retrieved 6 May 2026.
- ↑ "Brazergoline Drug Profile". Ozmosi. 1 January 1900. Retrieved 6 May 2026.
- 1 2 "BRAZERGOLINE". Inxight Drugs. Retrieved 6 May 2026.
 | This antihypertensive-related article is a stub. You can help Wikipedia by adding missing information. |